Мочевая кислота и функция эндотелия микроциркуляторного русла у больных на ранних стадиях артериальной гипертонии

1. Meredith IT, Yeung AC, Weidinger FF et al. Role of impaired endotheliuin-dependent vasodilatioii in iscnemic manifestations of coronary artery disease. Circulation 1993; 87 (SV): 56-6.

2. Rizzoni D, Porteri E, Castellano M et al. Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension 1998; 31 (pt 2): 335-41.

3. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-7.

4. Федорович А.А. Функциональное состояние регуляторных механизмов микроциркуляторного кровотока в норме и при артериальной гипертензии по данным лазерной допплеровской флоуметрии. Региональное кровообращение и микроциркуляция. 2010; 9 (33): 49-60.

5. Крупаткин А.И., Сидоров В.В. Лазерная допплеровская флоуметрия микроциркуляции крови. М.: Медицина, 2005; с. 254.

6. Маколкин В.И., Подзолков В.И., Бранько В.В. и др. Микроциркуляция в кардиологии. М.: 2004; с. 131.

7. Luscher TF, Noll G. The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. Atherosclerosis 1995; (Suppl.) 118: 8190.

8. Van Zwieten PA. Endothelial dysfunction in hypertension. A critical evaluation. Blood Press 1997; (Suppl.) 2: 6770.

9. Vanhoutte PM. Endothelial dysfunction in hypertension J Hypertens 1996; (Suppl.) 14 (5): 8393.

10. Boulanger C, Vanhoutte PM. The role of the endothelium in the regulation of vasomotor activity. Arch Mal Coeur Vaiss 1991; 84 (Spec.) 1: 3544.

11. Van Zwieten PA. Endothelial dysfunction in hypertension. A critical evaluation. Blood Press 1997; (Suppl.) 2: 6770.

12. Zoccali C, Maio R, Mallamaci F et al. Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 2006; 17: 1466-7.

13. Khosla UM, Zharikov S, Finch JL et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-42.

14. Verdechia P, Schilaci G, Reboldi G. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000; 36: 1072-8.

15. Faig DL, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003; 42: 247-52.

16. Band FN, McGee DL, Kennel WB. Hyperuricemia as a risk factor of coronary heart disease: the Framinghem Heart Study. Am J Epidemiology 1985; 121 (1): 11-8.

17. Fang J, Alderman MN. Serum uric acid and cardiovascular mortality: The NHANES I Epidemiologic Follow-up study 1971-1992. National Health and nutrition Examination survey. Am Med Assoc 2000; 238; 2404-10.

18. Meisinger C, Koenig W, Baumert J, Doring A. Uric Acid Levels Are Associated With All-Cause and Cardiovascular Disease Mortality Independent of Systemic Inflammation in Men From the General Population. The MONICA/KORA Cohort Study. Arterioscler Thromb Vasc Biol 2008; 28: 1186-92.

19. Методические аспекты применения метода лазерной допплеровской флоуметрии. Чуян Е.Н., Трибрат Н.С. Серия Биология; Химия 2008; 21 (60); 2: 156-71.

20. Stefanovska A, Bracic M, Kvernmo HD. Wavelet analysis of oscillations in peripheral blood circulation measured by Doppler technique. IEEE Trans Biomed Eng 1999; 46: 1230-9.

21. Klijn E, Lagrand WK et al. The microcirculation in health and critical disease. Prog Cardiovasc Dis 2008; 51: 161-70.

22. Stroes ES, Koomans НА, de Bmin TW, Rabelink ТJ. Vascular function in the forearm of hypercholesterolaemic patients off and оn lipid-lowering medication. Lancet 1995; 346: 467-71.

23. Annuk M, Zilmer M, Lind L et al. Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 2001; 12: 2747-52.

24. Johnson RJ, Kang D-H, Feig D et al. Is there a pathogenic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-90.

25. Corry DB, Eslami P, Yamamoto K et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J. Hypertension 2008; 26 (2): 269-75.

26. Sautin YY, Nakagawa T, Zharikov S et al. Adverse effects of the ckassical antioxidant uric acid in adypocites: NAD-PH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007; 293: 584-96.

27. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-15.

28. Moncoda S, Radomski MW, Palmer RMJ. Endothelium-derived relaxing factor: identification of nitric oxide and role in the control of vascular tone and platelet function. Biochem. Pharmacology 1988; 37: 2495-2501.

29. Mazzali M, Hughes J, Kim Yooh-Goo et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38: 1101-06.

30. Бойцов С.А., Федорович А.А., Рогоза А.Н. Основные параметры микроциркуляторного кровотока в норме по данным лазерной допплеровской флоуметрии. Национальный медико-хирургический центр им. Н.И.Пирогова. Научные труды. Москва, РАЕН: 2009; 2: 86-101.